<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Artiva Biotherapeutics Inc</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sun, 19 Apr 2026 20:48:02 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>ArtivaBio - Quelle für eiskalte natürliche Killer</title>
<link>http://www.aktiencheck.de/forum/ArtivaBio_Quelle_fuer_eiskalte_natuerliche_Killer-A3CPAK-t585409</link>
<guid>http://www.aktiencheck.de/forum/ArtivaBio_Quelle_fuer_eiskalte_natuerliche_Killer-A3CPAK-t585409</guid>
<description>Q1 2025 Report, Crwe World | Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business HighlightsIND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis     First trial to explore an allogeneic https://www.crweworld. [&lt;a href=&#034;http://www.aktiencheck.de/forum/ArtivaBio_Quelle_fuer_eiskalte_natuerliche_Killer-A3CPAK-t585409&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







